133 related articles for article (PubMed ID: 16760798)
1. Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption.
Molina-Pinelo S; Vivancos J; De Felipe B; Soriano-Sarabia N; Valladares A; De la Rosa R; Vallejo A; Leal M
J Acquir Immune Defic Syndr; 2006 Jun; 42(2):203-6. PubMed ID: 16760798
[TBL] [Abstract][Full Text] [Related]
2. High thymic volume is associated with viral replication and immunologic impairment only early after HAART interruption in chronic HIV infection.
Vallejo A; Valladares A; De Felipe B; Vivancos J; Gutierrez S; Soriano-Sarabia N; Ruiz-Mateos E; Lissen E; Leal M
Viral Immunol; 2005; 18(4):740-6. PubMed ID: 16359240
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
4. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
5. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
[TBL] [Abstract][Full Text] [Related]
6. Safe treatment interruptions in patients with nadir CD4 counts of more than 350 cells/microL: a randomized trial.
Krolewiecki AJ; Zala C; Vanzulli C; Pérez H; Iannella Mdel C; Bouzas MB; Gun A; Valiente J; Cassetti I; Cahn P
J Acquir Immune Defic Syndr; 2006 Apr; 41(4):425-9. PubMed ID: 16652049
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
[TBL] [Abstract][Full Text] [Related]
8. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
10. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
[TBL] [Abstract][Full Text] [Related]
12. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
[TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
14. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
Assoumou L; Weiss L; Piketty C; Burgard M; Melard A; Girard PM; Rouzioux C; Costagliola D;
AIDS; 2015 Sep; 29(15):2003-7. PubMed ID: 26355572
[TBL] [Abstract][Full Text] [Related]
15. Baseline thymic volume is a predictor for CD4 T cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy.
de la Rosa R; Leal M; Rubio A; Martinez-Moya M; Delgado J; Ruíz-Mateos E; Merchante E; Sánchez-Quijano A; Eduordo L;
Antivir Ther; 2002 Sep; 7(3):159-63. PubMed ID: 12487382
[TBL] [Abstract][Full Text] [Related]
16. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
17. Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
Porter BO; Anthony KB; Shen J; Hahn B; Keh CE; Maldarelli F; Blackwelder WC; Lane HC; Kovacs JA; Davey RT; Sereti I
AIDS; 2009 Jan; 23(2):203-12. PubMed ID: 19098490
[TBL] [Abstract][Full Text] [Related]
18. Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.
Ruiz-Mateos E; de la Rosa R; Soriano N; Martinez-Moya M; Rubio A; Sánchez-Quijano A; Lissen E; Leal M
Antivir Ther; 2003 Aug; 8(4):289-94. PubMed ID: 14518697
[TBL] [Abstract][Full Text] [Related]
19. CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.
Mussini C; Bedini A; Borghi V; Guaraldi G; Esposito R; Barchi E; Enilia R; Cozzi-Lepri A; Philips AN; Ortolani P; Bratt G; Eriksson LE; Sighinolfi L; Cossarizza A; d'Arminio Monforte A; De Luca A; Di Giambenedetto S; Antinori A;
AIDS; 2005 Feb; 19(3):287-94. PubMed ID: 15718839
[TBL] [Abstract][Full Text] [Related]
20. Thymic function in HIV-infection.
Kolte L
Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
